Ganoderma Lucidum (Reishi) Inhibits Cancer Cell Growth and Expression of Key Molecules in Inflammatory Breast Cancer

Overview

Journal Nutr Cancer

Publisher Routledge

Specialties Nutritional Sciences
Oncology

Date 2011 Sep 6

PMID 21888505

Citations 33

Authors

Michelle M Martinez-Montemayor

Raysa Rosario Acevedo

Elisa Otero-Franqui

Luis A Cubano

Suranganie F Dharmawardhane

Affiliations

Soon will be listed here.

Abstract

Inflammatory breast cancer (IBC) is the most lethal and least understood form of advanced breast cancer. Its lethality originates from its nature of invading the lymphatic system and absence of a palpable tumor mass. Different from other metastatic breast cancer cells, IBC cells invade by forming tumor spheroids that retain E-cadherin-based cell-cell adhesions. Herein we describe the potential of the medicinal mushroom Ganoderma lucidum (Reishi) as an attractive candidate for anti-IBC therapy. Reishi contains biological compounds that are cytotoxic against cancer cells. We report the effects of Reishi on viability, apoptosis, invasion, and its mechanism of action in IBC cells (SUM-149). Results show that Reishi selectively inhibits cancer cell viability although it does not affect the viability of noncancerous mammary epithelial cells. Apoptosis induction is consistent with decreased cell viability. Reishi inhibits cell invasion and disrupts the cell spheroids that are characteristic of the IBC invasive pathology. Reishi decreases the expression of genes involved in cancer cell survival and proliferation (BCL-2, TERT, PDGFB), and invasion and metastasis (MMP-9), whereas it increases the expression of IL8. Reishi reduces BCL-2, BCL-XL, E-cadherin, eIF4G, p120-catenin, and c-Myc protein expression and gelatinase activity. These findings suggest that Reishi is an effective anti-IBC therapeutic.

Citing Articles

Selective Antineoplastic Potential of Fractionated Caribbean Native Species Extracts on Triple-Negative Breast Cancer Cells.

Arroyo-Cruz L, Sagardia-Gonzalez S, Miller K, Ling T, Rivas F, Martinez-Montemayor M Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065715 PMC: 11279663. DOI: 10.3390/ph17070864.

Medicinal Mushrooms in Metastatic Breast Cancer: What Is Their Therapeutic Potential as Adjuvant in Clinical Settings?.

De Luca F, Roda E, Rossi P, Bottone M Curr Issues Mol Biol. 2024; 46(7):7577-7591.

PMID: 39057091 PMC: 11276109. DOI: 10.3390/cimb46070450.

Anti-Cancer Potential of Edible/Medicinal Mushrooms in Breast Cancer.

Gariboldi M, Marras E, Ferrario N, Vivona V, Prini P, Vignati F Int J Mol Sci. 2023; 24(12).

PMID: 37373268 PMC: 10299416. DOI: 10.3390/ijms241210120.

Mycochemicals against Cancer Stem Cells.

Tacchini M, Sacchetti G, Guerrini A, Paganetto G Toxins (Basel). 2023; 15(6).

PMID: 37368660 PMC: 10303916. DOI: 10.3390/toxins15060360.

Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis.

Ortiz-Soto G, Babilonia-Diaz N, Lacourt-Ventura M, Rivera-Rodriguez D, Quinones-Rodriguez J, Colon-Vargas M Int J Mol Sci. 2023; 24(5).

PMID: 36902125 PMC: 10002532. DOI: 10.3390/ijms24054694.

References

YUN T . Update from Asia. Asian studies on cancer chemoprevention. Ann N Y Acad Sci. 2000; 889:157-92. DOI: 10.1111/j.1749-6632.1999.tb08734.x. View

Van den Eynden G, Van der Auwera I, Van Laere S, Colpaert C, van Dam P, Merajver S . Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer. Breast Cancer Res Treat. 2004; 85(1):13-22. DOI: 10.1023/B:BREA.0000021028.33926.a8. View

Jiang J, Grieb B, Thyagarajan A, Sliva D . Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int J Mol Med. 2008; 21(5):577-84. View

Martinez-Montemayor M, Otero-Franqui E, Martinez J, De La Mota-Peynado A, Cubano L, Dharmawardhane S . Individual and combined soy isoflavones exert differential effects on metastatic cancer progression. Clin Exp Metastasis. 2010; 27(7):465-80. PMC: 2944964. DOI: 10.1007/s10585-010-9336-x. View

Tang W, Liu J, Zhao W, Wei D, Zhong J . Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci. 2006; 80(3):205-11. DOI: 10.1016/j.lfs.2006.09.001. View

Azios N, Krishnamoorthy L, Harris M, Cubano L, Cammer M, Dharmawardhane S . Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells. Neoplasia. 2007; 9(2):147-58. PMC: 1813930. DOI: 10.1593/neo.06778. View

Shenkier T, Weir L, Levine M, Olivotto I, Whelan T, Reyno L . Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CMAJ. 2004; 170(6):983-94. PMC: 359433. DOI: 10.1503/cmaj.1030944. View

Price J, Thompson E . Mechanisms of tumour invasion and metastasis: emerging targets for therapy. Expert Opin Ther Targets. 2002; 6(2):217-33. DOI: 10.1517/14728222.6.2.217. View

Shirakawa K, Kobayashi H, Heike Y, Kawamoto S, Brechbiel M, Kasumi F . Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res. 2002; 62(2):560-6. View

10.

Oude Weernink P, Verheul E, Kerkhof E, van Veelen C, Rijksen G . Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines. Neurosurgery. 1996; 38(1):108-13; discussion 113-4. DOI: 10.1097/00006123-199601000-00026. View

11.

Bjorklund M, Koivunen E . Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta. 2005; 1755(1):37-69. DOI: 10.1016/j.bbcan.2005.03.001. View

12.

Dong H, Liu G, Hou Y, Wu J, Lu J, Luo J . Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro. J Cancer Res Clin Oncol. 2006; 133(2):83-92. DOI: 10.1007/s00432-006-0140-6. View

13.

Tomlinson J, Alpaugh M, Barsky S . An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res. 2001; 61(13):5231-41. View

14.

Schlachterman A, Valle F, Wall K, Azios N, Castillo L, Morell L . Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol. 2008; 1(1):19-27. PMC: 2510765. DOI: 10.1593/tlo.07100. View

15.

Price J, Bonovich M, Kohn E . The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol. 1997; 32(3):175-253. DOI: 10.3109/10409239709082573. View

16.

Castillo-Pichardo L, Martinez-Montemayor M, Martinez J, Wall K, Cubano L, Dharmawardhane S . Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clin Exp Metastasis. 2009; 26(6):505-16. PMC: 2898569. DOI: 10.1007/s10585-009-9250-2. View

17.

Sliva D . Cellular and physiological effects of Ganoderma lucidum (Reishi). Mini Rev Med Chem. 2004; 4(8):873-9. DOI: 10.2174/1389557043403323. View

18.

Kim K, Kim J, Son J, Kim I . Enhanced induction of mitochondrial damage and apoptosis in human leukemia HL-60 cells by the Ganoderma lucidum and Duchesnea chrysantha extracts. Cancer Lett. 2006; 246(1-2):210-7. DOI: 10.1016/j.canlet.2006.02.014. View

19.

Jiang J, Slivova V, Harvey K, Valachovicova T, Sliva D . Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer. 2004; 49(2):209-16. DOI: 10.1207/s15327914nc4902_13. View

20.

Liotta L, Saidel M, KLEINERMAN J . The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res. 1976; 36(3):889-94. View